These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 28641766)

  • 21.
    Cho H; Baek MS; Choi JY; Lee SH; Kim JS; Ryu YH; Lee MS; Lyoo CH
    Neurology; 2017 Sep; 89(11):1170-1178. PubMed ID: 28814462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amyloid- and FDG-PET imaging in amyotrophic lateral sclerosis.
    Matías-Guiu JA; Pytel V; Cabrera-Martín MN; Galán L; Valles-Salgado M; Guerrero A; Moreno-Ramos T; Matías-Guiu J; Carreras JL
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2050-60. PubMed ID: 27262702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence of diffuse cerebellar neuroinflammation in multiple sclerosis by
    Barletta VT; Herranz E; Treaba CA; Ouellette R; Mehndiratta A; Loggia ML; Klawiter EC; Ionete C; Jacob SA; Mainero C
    Mult Scler; 2020 May; 26(6):668-678. PubMed ID: 30973800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Choroid Plexus Enlargement in Inflammatory Multiple Sclerosis: 3.0-T MRI and Translocator Protein PET Evaluation.
    Ricigliano VAG; Morena E; Colombi A; Tonietto M; Hamzaoui M; Poirion E; Bottlaender M; Gervais P; Louapre C; Bodini B; Stankoff B
    Radiology; 2021 Oct; 301(1):166-177. PubMed ID: 34254858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of early-phase [
    Daerr S; Brendel M; Zach C; Mille E; Schilling D; Zacherl MJ; Bürger K; Danek A; Pogarell O; Schildan A; Patt M; Barthel H; Sabri O; Bartenstein P; Rominger A
    Neuroimage Clin; 2017; 14():77-86. PubMed ID: 28138429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas.
    Park E; Gallezot JD; Delgadillo A; Liu S; Planeta B; Lin SF; O'Connor KC; Lim K; Lee JY; Chastre A; Chen MK; Seneca N; Leppert D; Huang Y; Carson RE; Pelletier D
    Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1081-92. PubMed ID: 25833352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo characterization of microglia and myelin relation in multiple sclerosis by combined
    Barletta VT; Herranz E; Treaba CA; Mehndiratta A; Ouellette R; Granberg T; Klawiter EC; Ionete C; Sloane JA; Mainero C
    J Neurol; 2023 Jun; 270(6):3091-3102. PubMed ID: 36859627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of [
    Lowe VJ; Lundt E; Knopman D; Senjem ML; Gunter JL; Schwarz CG; Kemp BJ; Jack CR; Petersen RC
    Neuroimage Clin; 2017; 16():295-302. PubMed ID: 28856092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlating new directional measures of myelin and axonal integrity in T2-weighted MRI with quantitative histology in multiple sclerosis.
    Sharma S; Laule C; Moore GRW; Li DKB; Zhang Y
    J Neurosci Methods; 2019 Jan; 311():369-376. PubMed ID: 30240805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand ¹¹C-PK11195.
    Rissanen E; Tuisku J; Rokka J; Paavilainen T; Parkkola R; Rinne JO; Airas L
    J Nucl Med; 2014 Jun; 55(6):939-44. PubMed ID: 24711650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ex vivo MR microscopy of a human brain with multiple sclerosis: Visualizing individual cells in tissue using intrinsic iron.
    Nair G; Dodd S; Ha SK; Koretsky AP; Reich DS
    Neuroimage; 2020 Dec; 223():117285. PubMed ID: 32828923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PET.
    Brendel M; Delker A; Rötzer C; Böning G; Carlsen J; Cyran C; Mille E; Gildehaus FJ; Cumming P; Baumann K; Steiner H; Haass C; Herms J; Bartenstein P; Rominger A
    Neuroimage; 2014 Jan; 84():843-53. PubMed ID: 24055703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal assessment of cerebral β-amyloid deposition in mice overexpressing Swedish mutant β-amyloid precursor protein using 18F-florbetaben PET.
    Rominger A; Brendel M; Burgold S; Keppler K; Baumann K; Xiong G; Mille E; Gildehaus FJ; Carlsen J; Schlichtiger J; Niedermoser S; Wängler B; Cumming P; Steiner H; Herms J; Haass C; Bartenstein P
    J Nucl Med; 2013 Jul; 54(7):1127-34. PubMed ID: 23729696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Magnetization transfer ratio measures in normal-appearing white matter show periventricular gradient abnormalities in multiple sclerosis.
    Liu Z; Pardini M; Yaldizli Ö; Sethi V; Muhlert N; Wheeler-Kingshott CA; Samson RS; Miller DH; Chard DT
    Brain; 2015 May; 138(Pt 5):1239-46. PubMed ID: 25823475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Normal appearing brain white matter changes in relapsing multiple sclerosis: Texture image and classification analysis in serial MRI scans.
    Loizou CP; Pantzaris M; Pattichis CS
    Magn Reson Imaging; 2020 Nov; 73():192-202. PubMed ID: 32890673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lesion filling effect in regional brain volume estimations: a study in multiple sclerosis patients with low lesion load.
    Pareto D; Sastre-Garriga J; Aymerich FX; Auger C; Tintoré M; Montalban X; Rovira A
    Neuroradiology; 2016 May; 58(5):467-74. PubMed ID: 26847633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Staging and quantification of florbetaben PET images using machine learning: impact of predicted regional cortical tracer uptake and amyloid stage on clinical outcomes.
    Kim JP; Kim J; Kim Y; Moon SH; Park YH; Yoo S; Jang H; Kim HJ; Na DL; Seo SW; Seong JK
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1971-1983. PubMed ID: 31884562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Partial-Volume Effect Correction Improves Quantitative Analysis of 18F-Florbetaben β-Amyloid PET Scans.
    Rullmann M; Dukart J; Hoffmann KT; Luthardt J; Tiepolt S; Patt M; Gertz HJ; Schroeter ML; Seibyl J; Schulz-Schaeffer WJ; Sabri O; Barthel H
    J Nucl Med; 2016 Feb; 57(2):198-203. PubMed ID: 26541776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the Effect of Fingolimod Treatment on Microglial Activation Using Serial PET Imaging in Multiple Sclerosis.
    Sucksdorff M; Rissanen E; Tuisku J; Nuutinen S; Paavilainen T; Rokka J; Rinne J; Airas L
    J Nucl Med; 2017 Oct; 58(10):1646-1651. PubMed ID: 28336784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imaging the multiple sclerosis lesion: insights into pathogenesis, progression and repair.
    Wang CT; Barnett M; Barnett Y
    Curr Opin Neurol; 2019 Jun; 32(3):338-345. PubMed ID: 30950846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.